The


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
24 Sep 2019
Historique:
received: 30 07 2019
revised: 19 09 2019
accepted: 21 09 2019
entrez: 27 9 2019
pubmed: 27 9 2019
medline: 12 2 2020
Statut: epublish

Résumé

In tumor cells of more than 20 different cancer types, the

Identifiants

pubmed: 31554271
pii: ijms20194740
doi: 10.3390/ijms20194740
pmc: PMC6801866
pii:
doi:

Substances chimiques

Aminoquinolines 0
Antineoplastic Agents 0
Benzimidazoles 0
Biomarkers 0
Butylamines 0
CXCL12 protein, human 0
CXCR4 protein, human 0
Chemokine CXCL12 0
Heterocyclic Compounds, 1-Ring 0
Receptors, CXCR4 0
mavorixafor 0G9LGB5O2W

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Austrian Science Fund
ID : T923-B26
Organisme : research grant of the MEFOgraz
ID : AD
Organisme : clinical, translational and ASHO research grant
ID : AD
Organisme : ASHO research grant
ID : KF

Références

Immunity. 2001 Aug;15(2):323-34
pubmed: 11520466
Semin Hematol. 2015 Apr;52(2):77-85
pubmed: 25805587
Blood. 2014 Mar 13;123(11):1637-46
pubmed: 24366360
J Exp Med. 2004 Nov 1;200(9):1145-56
pubmed: 15520246
Int J Hematol. 2003 May;77(4):321-9
pubmed: 12774918
Clin Cancer Res. 2013 Jul 1;19(13):3495-507
pubmed: 23637121
J Pathol. 2015 Feb;235(3):445-55
pubmed: 25231113
Nat Commun. 2011 Jul 19;2:402
pubmed: 21772273
Blood. 2007 Apr 15;109(8):3500-4
pubmed: 17197434
J Clin Oncol. 2005 Aug 1;23(22):5027-33
pubmed: 15955905
Cancer Res. 2017 May 1;77(9):2375-2386
pubmed: 28249906
Leuk Lymphoma. 2002 Nov;43(11):2179-89
pubmed: 12533045
Curr Med Chem. 2019;26(17):3026-3041
pubmed: 28875842
Sci Rep. 2018 Sep 28;8(1):14528
pubmed: 30266952
J Pathol. 2011 Jan;223(2):274-82
pubmed: 21125680
Mod Pathol. 2016 Sep;29(9):1050-7
pubmed: 27282353
PLoS One. 2014 Mar 11;9(3):e90518
pubmed: 24618817
Blood. 1992 Jul 15;80(2):459-69
pubmed: 1378321
Blood. 2014 May 1;123(18):2791-6
pubmed: 24553177
Mol Cancer Ther. 2014 May;13(5):1155-69
pubmed: 24502926
Oncotarget. 2019 Jan 22;10(7):717-731
pubmed: 30774774
Clin Cancer Res. 2016 Mar 1;22(5):1138-49
pubmed: 26467384
Onco Targets Ther. 2013 Sep 30;6:1347-61
pubmed: 24124379
J Exp Med. 2003 Nov 3;198(9):1391-402
pubmed: 14597738
Biochem J. 2004 Aug 1;381(Pt 3):635-44
pubmed: 15109307
Pancreas. 2015 May;44(4):528-34
pubmed: 25872129
Br J Haematol. 2007 Jan;136(2):286-93
pubmed: 17278262
N Engl J Med. 2008 Nov 27;359(22):2313-23
pubmed: 19038878
Pharmacol Ther. 2010 Dec;128(3):509-18
pubmed: 20826182
Oncol Rep. 2018 Jul;40(1):303-308
pubmed: 29749473
Bioinformatics. 2010 Oct 1;26(19):2363-7
pubmed: 20688976
Semin Hematol. 2015 Apr;52(2):67-76
pubmed: 25805586
N Engl J Med. 2010 Apr 15;362(15):1417-29
pubmed: 20393178
Cancer Biol Ther. 2010 Mar 15;9(6):409-16
pubmed: 20147779
Blood. 2014 May 22;123(21):3286-95
pubmed: 24659631
Int J Mol Sci. 2018 Nov 09;19(11):null
pubmed: 30423905
Blood. 2014 Apr 10;123(15):2367-77
pubmed: 24553175
Blood. 2014 Mar 13;123(11):1681-90
pubmed: 24037725
Acta Haematol. 2019;142(2):64-70
pubmed: 31096215
Leuk Res. 2010 Mar;34(3):379-86
pubmed: 20117835
J Exp Med. 2015 May 4;212(5):775-92
pubmed: 25847947
Cancer Metastasis Rev. 2010 Dec;29(4):709-22
pubmed: 20839032
Adv Cancer Res. 2014;124:31-82
pubmed: 25287686
Am J Med Sci. 2019 Apr;357(4):302-310
pubmed: 30904045
Cancer Res. 2007 Sep 15;67(18):8605-14
pubmed: 17875700
Oncol Rep. 2012 Dec;28(6):2239-46
pubmed: 23023480
Korean J Intern Med. 2014 Nov;29(6):785-92
pubmed: 25378977
Blood. 2015 Jan 1;125(1):40-7
pubmed: 25499449
Oncotarget. 2015 Mar 20;6(8):5597-614
pubmed: 25704881
Mod Pathol. 2013 Feb;26(2):182-94
pubmed: 22936065
Theranostics. 2013;3(1):47-75
pubmed: 23382786
Future Oncol. 2014 Apr;10(5):749-59
pubmed: 24799056
J Biol Chem. 2005 Oct 21;280(42):35760-6
pubmed: 16107333
Front Physiol. 2014 Jun 11;5:212
pubmed: 24966838
Immunology. 2005 Sep;116(1):1-12
pubmed: 16108812
J Thorac Cardiovasc Surg. 2012 Nov;144(5):1167-1175.e1
pubmed: 22925564
Leuk Lymphoma. 2018 Jun;59(6):1451-1460
pubmed: 28952842
PLoS One. 2018 Jun 19;13(6):e0198789
pubmed: 29920526
Front Immunol. 2018 Jun 12;9:1313
pubmed: 29951060
Eur J Immunol. 1997 Jul;27(7):1788-93
pubmed: 9247593
Blood. 2004 Jan 1;103(1):275-82
pubmed: 14504078
Pathology. 2010 Apr;42(3):212-6
pubmed: 20350212
J Exp Med. 2002 Jul 1;196(1):65-75
pubmed: 12093871

Auteurs

Katrin Pansy (K)

Division of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. katrin.pansy@medunigraz.at.

Julia Feichtinger (J)

Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Medical University of Graz, Neue Stiftingtalstraße 6/II, 8010 Graz, Austria. julia.feichtinger@medunigraz.at.

Barbara Ehall (B)

Division of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. barbara.ehall@medunigraz.at.

Barbara Uhl (B)

Division of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. barbara.uhl@medunigraz.at.

Miriam Sedej (M)

Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Universitätsplatz 4/I, 8010 Graz, Austria. miriam.sedej@medunigraz.at.

David Roula (D)

Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Universitätsplatz 4/I, 8010 Graz, Austria. david.roula@medunigraz.at.

Beata Pursche (B)

Division of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. Beata_Prusche@yahoo.de.

Axel Wolf (A)

Division of General Otorhinolaryngology, Medical University of Graz, Auenbruggerplatz 26, 8036 Graz, Austria. axel.wolf@klinikum-graz.at.

Manuel Zoidl (M)

Institute of Organic Chemistry, Graz University of Technology, Stremayrgasse 9/4, 8010 Graz, Austria. manuel.zoidl@tugraz.at.

Elisabeth Steinbauer (E)

Diagnostic & Research Institute of Pathology, Medical University Graz, Neue Stiftingtalstraße 6, 8010 Graz, Austria. elisabeth.steinbauer@klinikum-graz.at.

Verena Gruber (V)

Diagnostic & Research Institute of Pathology, Medical University Graz, Neue Stiftingtalstraße 6, 8010 Graz, Austria. verena.gruber@klinikum-graz.at.

Hildegard T Greinix (HT)

Division of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. hildegard.greinix@medunigraz.at.

Katharina T Prochazka (KT)

Division of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. KatharinaTheresa.Prochazka@klinikum-graz.at.

Gerhard G Thallinger (GG)

Institute of Computational Biotechnology, Graz University of Technology, Petersgasse 14/V, 8010 Graz, Austria. gerhard.thallinger@tugraz.at.
OMICS Center Graz, BioTechMed Graz, Stiftingtalstraße 24, 8010 Graz, Austria. gerhard.thallinger@tugraz.at.

Akos Heinemann (A)

Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Universitätsplatz 4/I, 8010 Graz, Austria. akos.heinemann@medunigraz.at.

Christine Beham-Schmid (C)

Diagnostic & Research Institute of Pathology, Medical University Graz, Neue Stiftingtalstraße 6, 8010 Graz, Austria. christine.beham@medunigraz.at.

Peter Neumeister (P)

Division of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. peter.neumeister@medunigraz.at.

Tanja M Wrodnigg (TM)

Institute of Organic Chemistry, Graz University of Technology, Stremayrgasse 9/4, 8010 Graz, Austria. t.wrodnigg@tugraz.at.

Karoline Fechter (K)

Division of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. fechterkaroline@gmail.com.

Alexander Ja Deutsch (AJ)

Division of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. alexander.deutsch@medunigraz.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH